Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer.

Simmons AR, Clarke CH, Badgwell DB, Lu Z, Sokoll LJ, Lu KH, Zhang Z, Bast RC Jr, Skates SJ.

Int J Gynecol Cancer. 2016 Jul;26(6):1070-7. doi: 10.1097/IGC.0000000000000737.

PMID:
27206285
2.

The added value of circulating tumor cells examination in ovarian cancer staging.

Kolostova K, Matkowski R, Jędryka M, Soter K, Cegan M, Pinkas M, Jakabova A, Pavlasek J, Spicka J, Bobek V.

Am J Cancer Res. 2015 Oct 15;5(11):3363-75. eCollection 2015.

3.

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, Crump DN, Davies SK, Dawnay A, Dobbs S, Fletcher G, Ford J, Godfrey K, Gunu R, Habib M, Hallett R, Herod J, Jenkins H, Karpinskyj C, Leeson S, Lewis SJ, Liston WR, Lopes A, Mould T, Murdoch J, Oram D, Rabideau DJ, Reynolds K, Scott I, Seif MW, Sharma A, Singh N, Taylor J, Warburton F, Widschwendter M, Williamson K, Woolas R, Fallowfield L, McGuire AJ, Campbell S, Parmar M, Skates SJ.

Lancet. 2016 Mar 5;387(10022):945-56. doi: 10.1016/S0140-6736(15)01224-6. Epub 2015 Dec 17. Erratum in: Lancet. 2016 Mar 5;387(10022):944.

4.

Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.

Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF.

J Natl Cancer Inst. 2015 Feb 16;107(4). pii: djv012. doi: 10.1093/jnci/djv012. Print 2015 Apr.

5.

A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.

Shadfan BH, Simmons AR, Simmons GW, Ho A, Wong J, Lu KH, Bast RC Jr, McDevitt JT.

Cancer Prev Res (Phila). 2015 Jan;8(1):37-48. doi: 10.1158/1940-6207.CAPR-14-0248. Epub 2014 Nov 11.

6.

In 2014, can we do better than CA125 in the early detection of ovarian cancer?

Cohen JG, White M, Cruz A, Farias-Eisner R.

World J Biol Chem. 2014 Aug 26;5(3):286-300. doi: 10.4331/wjbc.v5.i3.286. Review.

7.

The chicken model of spontaneous ovarian cancer.

Hawkridge AM.

Proteomics Clin Appl. 2014 Oct;8(9-10):689-99. doi: 10.1002/prca.201300135. Review.

PMID:
25130871
8.

A statistical challenge: developing tests for biomarker utility specific to the intended use.

Skates SJ.

J Natl Cancer Inst. 2014 Apr;106(4):dju076. doi: 10.1093/jnci/dju076. Epub 2014 Mar 28. No abstract available.

9.

Ovarian cancer screening--current status, future directions.

Menon U, Griffin M, Gentry-Maharaj A.

Gynecol Oncol. 2014 Feb;132(2):490-5. doi: 10.1016/j.ygyno.2013.11.030. Epub 2013 Dec 3. Review.

10.

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies.

Schmitt M, Magdolen V, Yang F, Kiechle M, Bayani J, Yousef GM, Scorilas A, Diamandis EP, Dorn J.

Radiol Oncol. 2013 Oct 8;47(4):319-29. doi: 10.2478/raon-2013-0053. eCollection 2013. Review.

11.

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.

Lu KH, Skates S, Hernandez MA, Bedi D, Bevers T, Leeds L, Moore R, Granai C, Harris S, Newland W, Adeyinka O, Geffen J, Deavers MT, Sun CC, Horick N, Fritsche H, Bast RC Jr.

Cancer. 2013 Oct 1;119(19):3454-61. doi: 10.1002/cncr.28183. Epub 2013 Aug 26.

12.

Multi-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer model.

Andrews Kingon GL, Petitte JN, Muddiman DC, Hawkridge AM.

Methods. 2013 Jun 15;61(3):323-30. doi: 10.1016/j.ymeth.2013.04.004. Epub 2013 Apr 19.

13.

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.

Rosenthal AN, Fraser L, Manchanda R, Badman P, Philpott S, Mozersky J, Hadwin R, Cafferty FH, Benjamin E, Singh N, Evans DG, Eccles DM, Skates SJ, Mackay J, Menon U, Jacobs IJ.

J Clin Oncol. 2013 Jan 1;31(1):49-57. doi: 10.1200/JCO.2011.39.7638. Epub 2012 Dec 3.

14.

A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum.

Opstal-van Winden AW, Rodenburg W, Pennings JL, van Oostrom CT, Beijnen JH, Peeters PH, van Gils CH, de Vries A.

Int J Mol Sci. 2012 Oct 22;13(10):13587-604. doi: 10.3390/ijms131013587.

15.

Measurement of phospholipids may improve diagnostic accuracy in ovarian cancer.

Shan L, Chen YA, Davis L, Han G, Zhu W, Molina AD, Arango H, LaPolla JP, Hoffman MS, Sellers T, Kirby T, Nicosia SV, Sutphen R.

PLoS One. 2012;7(10):e46846. doi: 10.1371/journal.pone.0046846. Epub 2012 Oct 17.

16.

Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer.

Urban N, Thorpe J, Karlan BY, McIntosh MW, Palomares MR, Daly MB, Paley P, Drescher CW.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2087-94. doi: 10.1158/1055-9965.EPI-12-0616. Epub 2012 Sep 7.

17.

Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age.

Moore RG, Miller MC, Eklund EE, Lu KH, Bast RC Jr, Lambert-Messerlian G.

Am J Obstet Gynecol. 2012 Apr;206(4):349.e1-7. doi: 10.1016/j.ajog.2011.12.028. Epub 2011 Dec 30.

18.

Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers.

Yip P, Chen TH, Seshaiah P, Stephen LL, Michael-Ballard KL, Mapes JP, Mansfield BC, Bertenshaw GP.

PLoS One. 2011;6(12):e29533. doi: 10.1371/journal.pone.0029533. Epub 2011 Dec 21.

19.

fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.

Hellstrom I, Hellstrom KE.

Expert Opin Med Diagn. 2011 May 1;5(3):227-240.

20.

Ovarian cancer screening and early detection in the general population.

Rauh-Hain JA, Krivak TC, Del Carmen MG, Olawaiye AB.

Rev Obstet Gynecol. 2011;4(1):15-21.

Items per page

Supplemental Content

Write to the Help Desk